Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Submitted by
admin
on January 18, 2023 - 9:50am
Source:
Motley Fool
News Tags:
Moderna Therapeutics
RSV
Bluebird Bio
NASDAQ
Headline:
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
snippet:
The Nasdaq kept leading markets higher.
Moderna stock rose after the company announced favorable trial results for its candidate RSV vaccine.
Bluebird Bio fell on news of a secondary stock offering.
Do Not Allow Advertisers to Use My Personal information